Know Cancer

or
forgot password

A Multi-centre, Naturalistic Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of EGFR TKI in Male Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer of Adeno Histology Failed 1st Line Chemotherapy


N/A
20 Years
N/A
Not Enrolling
Male
Non Small Cell Lung Cancer

Thank you

Trial Information

A Multi-centre, Naturalistic Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of EGFR TKI in Male Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer of Adeno Histology Failed 1st Line Chemotherapy


Inclusion Criteria:



- Male patients age 20 years or older

- Histological or cytological confirmation of NSCLC of adeno histology. If sputum is
the only available sample, a second positive test is necessary for cytological
confirmation

- Locally advanced or metastatic on or after first-line chemotherapy. Imaging evidence
of disease progression can be either chest X ray, CT or MRI assessment on measurable
lesions. If no measurable lesion is available, evaluable lesions are acceptable

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Correlation between smoking patterns and best objective tumor response rate

Outcome Time Frame:

6 Months

Safety Issue:

No

Principal Investigator

Chun-Ming Tsai, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Taipei Ventrans General Hospital

Authority:

Taiwan: Institutional Review Board

Study ID:

NIS-OTW-IRE-2009/1

NCT ID:

NCT00922025

Start Date:

August 2009

Completion Date:

December 2010

Related Keywords:

  • Non Small Cell Lung Cancer
  • NSCLC
  • Male
  • Smoking Pattern
  • Efficacy
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Smoking

Name

Location